# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001933
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:55
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | atxs-20240930x10q.htm iXBRL | 10-Q | 1351754
2 | EX-31.1 | atxs-20240930xex31d1.htm | EX-31.1 | 11120
3 | EX-31.2 | atxs-20240930xex31d2.htm | EX-31.2 | 11133
4 | EX-32.1 | atxs-20240930xex32d1.htm | EX-32.1 | 6673
| Complete submission text file | 0001410578-24-001933.txt |  | 5537898

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | atxs-20240930.xsd | EX-101.SCH | 35118
6 | EX-101.CAL | atxs-20240930_cal.xml | EX-101.CAL | 40686
7 | EX-101.DEF | atxs-20240930_def.xml | EX-101.DEF | 153834
8 | EX-101.LAB | atxs-20240930_lab.xml | EX-101.LAB | 353716
9 | EX-101.PRE | atxs-20240930_pre.xml | EX-101.PRE | 244470
62 | EXTRACTED XBRL INSTANCE DOCUMENT | atxs-20240930x10q_htm.xml | XML | 909876

Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 241453880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)